TMCnet News
Ovarian Cancer - Pipeline Review, H2 2016 - Research and MarketsResearch and Markets has announced the addition of the "Ovarian Cancer - Pipeline Review, H2 2016" report to their offering. Ovarian cancer is any cancerous growth that may occur in different parts of the ovary. The majority of ovarian cancers arise from the epithelium (outer lining) of the ovary. Signs and symptoms of ovarian cancer include pelvic discomfort or pain, indigestion, gas or nausea, changes in bowel habits, such as constipation, loss of appetite and low back pain. The predisposing factors include age and family history. Treatment includes surgery, chemotherapy and radiation therapy. This report provides comprehensive information on the therapeutic development for Ovarian Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Ovarian Cancer and special features on late-stage and discontinued projects. The report enhances decision making capabilities and help to create ffective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Companies Mentioned:
Key Topics Covered:
For more information about this report visit http://www.researchandmarkets.com/research/m6lqgb/ovarian_cancer View source version on businesswire.com: http://www.businesswire.com/news/home/20170206005528/en/ |
